Back to MW MARSHALL WACE, LLP

CRMDCRMD
Showing 8 of 20 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CORMEDIX INC

MARSHALL WACE, LLP holds 779,535 shares of CRMD (CORMEDIX INC), worth $6.1M as of 2026-Q2. The position was increased (+55.0% shares). CRMD represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$6.1M

Current Shares

779,535

Total Value Change

+$4.8M

Total Shares Change

+617,780

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
779,535
+55.0%
$6.1M0.0%$7.85
38
2026-Q1
Decreased
502,965
-74.4%
$3.4M0.0%$6.91
0
2025-Q4
Decreased
2M
-43.4%
$22.9M0.0%$12.48
0
2025-Q3
Increased
3.5M
+34.6%
$40.4M0.0%$11.85
38
2025-Q2
Increased
2.6M
+1019.2%
$31.8M0.0%$12.50
47
2025-Q1
New
230,525
-
$1.4M0.0%$6.74
35
2024-Q4
Exited
0
-100.0%
$00.0%$8.10
0
2024-Q3
Increased
161,755
+6.2%
$1.3M0.0%$8.05
27

Other major holders of CRMD: Steward Partners Investment Advisory, LLC, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used